Intelligence / Healthtech / New Clinical Trials / AstraZeneca
Clinicaltrial registered20 Oct 2026
AstraZeneca
20 Oct 2026: Trial registered · A Study to Evaluate Treatment Patterns and Investigate Adult Patients With B-cell Lymphoma. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 20 Oct 2026
- Title
- A Study to Evaluate Treatment Patterns and Investigate Adult Patients With B-cell Lymphoma
- Conditions
- Lymphoma, B-Cell
- Study Type
- Observational
- Status
- Not Yet Recruiting
- Countries
- Brazil
- Country
- Brazil
- Reference
- NCT07882576
- Location
- Brazil
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at AstraZeneca
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
Across AOS Research
Other records for AstraZeneca in our registers.
18 NovAstraZenecatrial registered · HealthtechClinical17 NovAstraZenecatrial registered · HealthtechClinical13 NovAstraZenecatrial registered · HealthtechClinical12 NovAstraZenecatrial registered · HealthtechClinical12 NovAstraZenecatrial registered · HealthtechClinical12 NovAstraZenecatrial registered · HealthtechClinical6 NovAstraZenecatrial registered · HealthtechClinical4 NovAstraZenecatrial registered · HealthtechClinical4 NovAstraZenecatrial registered · HealthtechClinical4 NovAstraZenecatrial registered · HealthtechClinical2 NovAstraZenecatrial registered · HealthtechClinical2 NovAstraZenecatrial registered · HealthtechClinical
More from Brazil
New Clinical Trials
17 NovAstraZenecatrial registered · A Study to Investigate the Efficacy and Safety of Dato-DXd-based Combinations in Participants With TROP2 NMR+ NSCLCClinical16 NovDr. August Wolff GmbH & Co. KG Arzneimitteltrial registered · Non-inferiority Study of a Hydroxyapatite and Calcium Hypophosphite Toothpaste Compared With Two Comparator Toothpastes in Dentin HypersensitivityClinical12 NovNovo Nordisk A/Strial registered · A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or BothClinical12 NovNovo Nordisk A/Strial registered · AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or BothClinical12 NovNovo Nordisk A/Strial registered · A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or BothClinical5 NovBrainfarma Industria Química e Farmacêutica S/Atrial registered · Cosmetic Efficacy Evaluation of Hydraporin AI Cream in Individuals With Atopic Dermatitis and PsoriasisClinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.